Arvada Therapeutics
Adam Cotton - Director
Cardiovascular
Boston, USA
Arvada Therapeutics is developing large-molecule therapeutics to treat arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.